Tuesday, August 25, 2026 Never miss a recall or a rule change Go Pro · $20/mo →
Inside MedSpa
FDA Recall & Compliance Alerts for Medspa Owners
InjectablesRHA Redensity Eye Wins FDA Nod for Under-Eye HollowstodayMarketGLP-1 Pill Era Is Forcing Beauty Market Shift2 days agoBusiness & M&AGalderma Opens Miami HQ for U.S. and Latin AmericatodayDevices & TechUltherapy PRIME Real-Time Imaging Reshapes Midface Lifting2 days agoDevices & TechMerz Partners with NANOTEC on Aesthetic LongevitytodayInjectablesAEON Releases Expanded ABP-450 Botox Biosimilar Data2 days agoDevices & TechXERF Technology Launches in Sydney for Skin TighteningtodayRegulatoryRevance Wins FDA Nod for Under-Eye Injectables2 days agoRegulatoryAbbVie Launches Phase 2 Forehead Lines StudyyesterdayDevices & TechSofwave Hits One Million Treatments MilestoneyesterdayBusiness & M&AAllergan Aesthetics Overhauls Loyalty ProgramyesterdayBusiness & M&AEvolus Expands Estyme to Canada, Australia, New Zealandyesterday
1 free article left this week. A free account gets you 4 a week.Go Pro →
Business & M&A

Steel Partners Bids $16.75/Share for InMode — What a Contested Takeover Means for Device Buyers

Unsolicited offer challenges CEO-led buyout; device consolidation accelerates.

Image: Inside MedSpa
1-YEAR MOVE
+3% −14%
INMD ▲1.0%
1-year price move by ticker
TickerCompany1-year change
INMDInMode Ltd.+1.0%

Steel Partners, already a significant InMode shareholder, has made an unsolicited $16.75-per-share cash offer to acquire the RF microneedling and energy-device manufacturer, topping a competing CEO-led buyout proposal. The move signals aggressive consolidation in the aesthetic-device space and raises questions about InMode's strategic direction and product roadmap under new ownership.

Steel Partners' $16.75-per-share bid tops the CEO-led offer, signaling a contested acquisition.

For practice owners, the immediate concern is continuity: device pricing, rebate structures, training support, and warranty terms often shift during ownership transitions. Steel Partners is a diversified industrial investor with no prior aesthetic-device operating experience, which could mean either hands-off stewardship or significant operational restructuring. The outcome of this bid battle will likely reshape InMode's go-to-market strategy and the economics of RF platforms for independent practices.

Source: original report ↗

Frequently asked questions

What happens to InMode device pricing if Steel Partners wins the takeover?

Pricing typically shifts during ownership transitions as new operators reassess margins and market positioning. Steel Partners' lack of prior aesthetic-device experience means they may either maintain current pricing or restructure rebate and warranty terms to improve profitability—practice owners should lock in pricing agreements now if possible.

Will InMode RF microneedling devices still be supported after a Steel Partners acquisition?

Support continuity is uncertain under new ownership. Steel Partners is a diversified industrial investor without aesthetic-device operating experience, so training, warranty, and technical support structures could remain stable or undergo significant restructuring depending on their operational strategy.

Should I buy an InMode device now before the takeover closes?

If you're considering purchase, now is a strategic time to negotiate—uncertainty often creates leverage for buyers seeking locked-in pricing, extended warranties, or favorable rebate terms. Contact your InMode rep to discuss transition protections before ownership changes hands.

What is Steel Partners' track record with medical device companies?

Steel Partners is a diversified industrial investor with no prior operating experience in aesthetic or medical devices, making this acquisition a new category for them. Their hands-off or restructuring approach will likely depend on InMode's profitability and market position post-acquisition.

How long will the InMode takeover battle take to resolve?

The article does not specify a timeline, but contested takeovers typically take 3-6 months to resolve through shareholder votes and regulatory approval. Practice owners should monitor official InMode communications for updates on the bid process and expected closing date.

What other aesthetic device companies might be affected by InMode consolidation?

The article indicates device consolidation is accelerating across the aesthetic space, though specific competitors are not named. This suggests RF and energy-device manufacturers may face similar acquisition pressure, potentially affecting pricing and availability across the market.

Free alerts

Free: recall & rule-change alerts for your practice.

Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.

Free · weekly · unsubscribe anytime. Privacy.

Stay three moves ahead of every practice in your market.

Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.

Get the edge · $20/mo

Join the owners who run ahead of the industry. Cancel anytime, one click.

Share

https://insidemedspa.com/article/steel-partners-inmode-acquisition-bid-16-75-per-share/

Discussion

    Leave a comment

    Comments are reviewed before they appear.
    Inside MedSpa Pro

    By the time it's news, it's too late.

    The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

    Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.
    The twice-a-week intelligence brief Go Pro · $20/mo